title: Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells.
abstract: Multidrug resistance (MDR) plays a major obstacle to successful gastric cancer chemotherapy. The purpose of this study was to investigate the MDR reversal effect and mechanisms of hyperthermia in combination with neferine (Nef) in adriamycin (ADM) resistant human SGC7901/ADM gastric cancer cells. The MDR cells were heated at 42°C and 45°C for 30 min alone or combined with 10 μg/mL Nef. The cytotoxic effect of ADM was evaluated by MTT assay. Cellular plasma membrane lipid fluidity was detected by fluorescence polarization technique. Intracellular accumulation of ADM was monitored with high performance liquid chromatography. Mdr-1 mRNA, P-glycoprotein (P-gp), γH2AX expression and γH2AX foci formation were determined by real-time PCR, Western blot and immunocytochemical staining respectively. It was found that different heating methods induced different cytotoxic effects. Water submerged hyperthermia had the strongest cytotoxicity of ADM and Nef combined with hyperthermia had a synergistic cytotoxicity of ADM in the MDR cells. The water submerged hyperthermia increased the cell membrane fluidity. Both water submerged hyperthermia and Nef increased the intracellular accumulation of ADM. The water submerged hyperthermia and Nef down-regulated the expression of mdr-1 mRNA and P-gp. The water submerged hyperthermia could damage DNA and increase the γH2AX expression of SGC7901/ADM cells. The higher temperature was, the worse effect was. Our results show that combined treatment of hyperthermia with Nef can synergistically reverse MDR in human SGC7901/ADM gastric cancer cells.
authors.affiliation: Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
authors.forename: Chenghui
authors.initials: C
authors.lastname: Huang
authors.affiliation: Epigenetics Research Center, Second Xiangya Hospital, Central South University, Changsha, 410011, China. lyplisa@yahoo.com.cn.
authors.forename: Yaping
authors.initials: Y
authors.lastname: Li
authors.affiliation: Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
authors.forename: Peiguo
authors.initials: P
authors.lastname: Cao
authors.affiliation: Department of Hematology, Xiangya Hospital, Central South University, Changsha, 410078, China.
authors.forename: Zhaoxia
authors.initials: Z
authors.lastname: Xie
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
authors.forename: Zhiqiang
authors.initials: Z
authors.lastname: Qin
mesh_terms: D044182:Benzylisoquinolines / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000009:adverse effects*; D018432:Drug Resistance, Multiple / Q000187:drug effects* / Q000502:physiology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects* / Q000502:physiology; D005334:Fever / Q000503:physiopathology*; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D044182:Benzylisoquinolines; C057222:neferine; D004317:Doxorubicin